INSIGHTS ON DRUG DEVELOPMENT

• Advancements In GLP-1 Analog Formulation: Overcoming Challenges

  Oral GLP-1 formulations represent a groundbreaking advance in obesity treatment to offer improved patient comfort and adherence while expanding the therapeutic market.

• The Delicate Dance: When Phase-Appropriate Decisions Carry More Risk

   Early drug development demands speed, but some decisions carry long-term consequences. Learn which process and analytical choices require teams to look beyond the next milestone.

• Automation Of 3D Intestinal Organoids Culture

  Gain insight into how 3D organoids promise better disease modeling and drug screening and how challenges like assay complexity, reproducibility, and scalability hinder their widespread adoption in drug discovery.

• Assessment Of Compound Toxicity Effects With High-Content Imaging

  3D cellular models and bioprinting enhance drug safety predictions and offer precise spatial control. Explore an automated method for generating liver models to improve reproducibility and reliability in toxicity testing.

• Enabling Quality By Design

  9/8/2025

  Outdated quality systems delay product release. Discover how manufacturers can harness real-time data, operationalize QbD, and enhance compliance, efficiency, and supply chain continuity.

• Biophysical Tools For Biotherapeutic Development

  6/26/2025

  Discover essential analytical techniques in biotherapeutics development, as well as explore ITC, DSC, and Rheology—powerful tools for understanding formulation, stability, and efficacy in drug development.

• Project Management: Sphere Of Influence

  10/21/2024

  The project manager's sphere of influence extends beyond the project team, encompassing the organization, industry, and professional discipline.

• Spray Dried Biologics For Pulmonary Dosage Forms

  5/8/2026

  View how spray drying enables stable, precisely engineered pulmonary powders for biologics, supporting efficient lung delivery, scalability, and preservation of molecular structure and activity.

• Advancing Cell Therapies With Lipid Nanoparticles

  3/24/2025

  Cell therapies, using reprogrammed immune cells, offer innovative treatments for diseases. Discover how lipid nanoparticles (LNPs) enhance these therapies by delivering RNA for gene modulation and next-gen treatments.